5,901 Shares in Prestige Consumer Healthcare Inc. $PBH Acquired by MQS Management LLC

MQS Management LLC purchased a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 5,901 shares of the company’s stock, valued at approximately $471,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Cerity Partners LLC raised its stake in Prestige Consumer Healthcare by 3.7% during the 1st quarter. Cerity Partners LLC now owns 3,666 shares of the company’s stock worth $315,000 after buying an additional 132 shares during the period. UMB Bank n.a. raised its stake in Prestige Consumer Healthcare by 81.8% during the 2nd quarter. UMB Bank n.a. now owns 320 shares of the company’s stock worth $26,000 after buying an additional 144 shares during the period. KBC Group NV raised its stake in Prestige Consumer Healthcare by 7.4% during the 1st quarter. KBC Group NV now owns 2,199 shares of the company’s stock worth $189,000 after buying an additional 151 shares during the period. Xponance Inc. raised its stake in Prestige Consumer Healthcare by 5.5% during the 1st quarter. Xponance Inc. now owns 3,766 shares of the company’s stock worth $324,000 after buying an additional 196 shares during the period. Finally, Resona Asset Management Co. Ltd. raised its stake in Prestige Consumer Healthcare by 2.3% during the 1st quarter. Resona Asset Management Co. Ltd. now owns 9,105 shares of the company’s stock worth $783,000 after buying an additional 203 shares during the period. 99.95% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

PBH has been the topic of a number of research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research note on Saturday. Zacks Research downgraded Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research note on Thursday, September 4th. Canaccord Genuity Group decreased their price objective on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating for the company in a report on Friday, August 8th. Oppenheimer decreased their price objective on Prestige Consumer Healthcare from $82.00 to $72.00 and set an “outperform” rating for the company in a report on Tuesday, October 21st. Finally, Sidoti raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 price objective for the company in a report on Wednesday, September 24th. Four investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Prestige Consumer Healthcare presently has an average rating of “Hold” and an average price target of $90.60.

Prestige Consumer Healthcare Stock Performance

Shares of PBH opened at $62.27 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. The stock has a 50 day moving average price of $64.06 and a two-hundred day moving average price of $74.64. The firm has a market capitalization of $3.06 billion, a P/E ratio of 14.62, a P/E/G ratio of 1.97 and a beta of 0.44. Prestige Consumer Healthcare Inc. has a 52 week low of $60.15 and a 52 week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.06). The company had revenue of $249.53 million for the quarter, compared to the consensus estimate of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The business’s revenue for the quarter was down 6.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.90 earnings per share. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. Equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.